Dextromethorphan-Quinidine in Treatment-Resistant Depression: An Open-Label Pilot Study

被引：0
|
作者：
Wang, Philip [1 ]
Yavi, Mani [1 ]
Park, Lawrence [1 ]
Zarate, Carlos [1 ]
机构：
[1] NIMH, Bethesda, MD 20892 USA
来源：
BIOLOGICAL PSYCHIATRY | 2023年 / 93卷 / 09期
基金：
美国国家卫生研究院;
关键词：
Clinical Trials; NMDA antagonists; Treatment Resistant Depression; Psychopharmacological Treatment; Dextromethorphan;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
208
引用
收藏
页码：S177 / S178
页数：2
相关论文
共 50 条
  • [41] Safety and Tolerability of Dextromethorphan/Quinidine for Pseudobulbar Affect in a 12-Week, Open-Label Extension Study
    Pioro, Erik
    Brooks, Benjamin
    Cummings, Jeffrey
    Schiffer, Randolph
    Wynn, Daniel
    Hepner, Adrian
    Viejo, Aliso
    Kaye, Randall
    NEUROLOGY, 2010, 74 (09) : A541 - A541
  • [42] An open-label feasibility study of repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression in the New Zealand healthcare context
    Godfrey, Kate E. M.
    Muthukumaraswamy, Suresh D.
    Stinear, Cathy M.
    Hoeh, Nicholas R.
    NEW ZEALAND MEDICAL JOURNAL, 2019, 132 (1504) : 46 - 55
  • [43] Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy
    Gaston, Tyler E.
    Szaflarski, Magdalena
    Hansen, Barbara
    Bebin, E. Martina
    Szaflarski, Jerzy P.
    EPILEPSY & BEHAVIOR, 2019, 95 : 10 - 17
  • [44] Yi-Gan San as Adjunctive Therapy for Treatment-Resistant Schizophrenia: An Open-Label Study
    Miyaoka, Tsuyoshi
    Furuya, Motohide
    Yasuda, Hideaki
    Hayashida, Maiko
    Nishida, Akira
    Inagaki, Takuji
    Horiguchi, Jun
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (01) : 6 - 9
  • [45] Open-label pilot study of adjunctive aripiprazole treatment for difficult to treat bipolar depression
    Metrick, M. S.
    Anand, A.
    BIPOLAR DISORDERS, 2008, 10 : 38 - 38
  • [46] Magnetic seizure therapy is efficacious and well tolerated for treatment-resistant bipolar depression: an open-label clinical trial
    Tang, Victor M.
    Blumberger, Daniel M.
    Dimitrova, Julia
    Throop, Alanah
    McClintock, Shawn M.
    Voineskos, Daphne
    Downar, Jonathan
    Knyahnytska, Yuliya
    Mulsant, Benoit H.
    Fitzgerald, Paul B.
    Daskalakis, Zafiris J.
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2020, 45 (05): : 313 - 321
  • [47] Mirtazapine in treatment of adolescents with major depression. An open-label, multicenter pilot study
    Haapasalo-Pesu, KM
    Vuola, T
    Lahdelma, L
    Marttunen, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S198 - S198
  • [48] An open-label trial of memantine in treatment-resistant obsessive-compulsive disorder
    Bakhla, Ajay Kumar
    Vijay
    Soren, Subhas
    Sarkhel, Sujit
    Choudhury, Suprakash
    INDIAN JOURNAL OF PSYCHIATRY, 2013, 55 (05) : S118 - S119
  • [49] Topiramate in the treatment of trichotillomania: an open-label pilot study
    Lochner, Christine
    Seedat, Soraya
    Niehaus, Dana J. H.
    Stein, Dan J.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (05) : 255 - 259
  • [50] An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder
    Menza, Matthew A.
    Dobkin, Roseanne D.
    Marin, Humberto
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (02) : 207 - 210
12345